Literature DB >> 31978516

Values of intravoxel incoherent motion diffusion weighted imaging and dynamic contrast-enhanced MRI in evaluating the activity of sacroiliitis in ankylosing spondylitis of rat model.

Jian Qin1, Jiang Li1, Hui Yang1, Mingsheng Jia1, Xiaoqian Li1, Qianqian Yao1, Yue Zhang1, Jianzhong Zhu1, Changqin Li2.   

Abstract

OBJECTIVE: To prospectively evaluate the ability of IVIM-DWI and DCE-MRI in detecting early activity of sacroiliitis in rat model of ankylosing spondylitis by comparing with pathological results.
METHODS: 20 wistar male rats were induced by bovine proteoglycan combined with complete/incomplete Freund's adjuvant as model group, and 20 healthy male rats were used as the control group. The parameters of IVIM-DWI and DCE-MRI in synovial regions of SIJ were measured respectively at 7th, 12th, 17th, and 22th weeks after the last induction, and the pathological features of SIJ were taken also, further studying the pathological characteristics of sacroiliac region. Independent sample t-test and one-way ANOVA were used for statistical analysis. The prediction parameters and diagnostic efficiency were compared by ROC curve.
RESULTS: There was no significant difference of image parameters between the model and control groups at the 7th, 12th weeks after the last induction, and there were no positive findings in histopathological examination at the same time. At the 17th week after induction, the f and Fenh%, Senh% between the model and the control groups were statistically significant. At the 22th week, there was a statistically significant increase all the values in model group than those in control group (P < 0.05). Histologic examination confirmed inflmmtorycell infiitrtion at the 17th week and pannus forming of synovium on the surface of cartilage at the 22th week in the model groups. The Fenh%, Senh%, Dslow and f had the moderate diagnostic efficiency and the areas under the curve were 0.77, 0.75, 0.77 and 0.82 respectively. The Senh% demonstrated the highest sensitivity (71.4%) and f demonstrated the highest specificity (95.0%).
CONCLUSION: IVIM-DWI and DCE-MRI can be used as the sensitive imaging methods to detect and accurate diagnosis the early activity of sacroiliitis in AS.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Animal model; Ankylosing spondylitis; Dynamic contract enhance; Intravoxel incoherent motion; MRI

Year:  2020        PMID: 31978516     DOI: 10.1016/j.mri.2020.01.007

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  5 in total

Review 1.  Pediatric skeletal diffusion-weighted magnetic resonance imaging, part 2: current and emerging applications.

Authors:  Apeksha Chaturvedi
Journal:  Pediatr Radiol       Date:  2021-05-21

2.  Comparative study of imaging and histology of sacroiliac joint in normal rats based on IVIM-DWI and DCE-MRI.

Authors:  Jian Qin; Qianqian Yao; Xubo Ge; Jianzhong Zhu; Zhaoliang Yin; Xiaoqian Li; Changqin Li
Journal:  BMC Musculoskelet Disord       Date:  2020-07-20       Impact factor: 2.362

3.  Quantitative DCE-MRI: an efficient diagnostic technique for evaluating early micro-environment permeability changes in ankylosing spondylitis.

Authors:  Hui Yang; Ling Jiang; Jiang Li; Xiuzhu Zheng; Qianqian Yao; Changqin Li; Jianzhong Zhu; Jian Qin
Journal:  BMC Musculoskelet Disord       Date:  2020-11-24       Impact factor: 2.362

4.  Tail suspension delays ectopic ossification in proteoglycan-induced ankylosing spondylitis in mice via miR-103/DKK1.

Authors:  Zhenzhen Zhang; Jing Zeng; Yang Li; Qing Liao; Dongdong Huang; Yucong Zou; Gang Liu
Journal:  Exp Ther Med       Date:  2021-07-07       Impact factor: 2.447

5.  Improved Performance of Compartments in Detecting the Activity of Axial Spondyloarthritis Based on IVIM DWI with Optimized Threshold b Value.

Authors:  Qiang Ye; Zhuoyao Xie; Chang Guo; Xing Lu; Kai Zheng; Yinghua Zhao
Journal:  Biomed Res Int       Date:  2022-01-10       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.